| Alberto L De Hoyos, MD | |
|
740 South Limestone, Room A301, Lexington, KY 40536 | |
| (859) 323-6494 | |
| Not Available |
| Full Name | Alberto L De Hoyos |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 42 Years |
| Location | 740 South Limestone, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851355333 | NPI | - | NPPES |
| 036103013 | Medicaid | IL | |
| 2378350 | Medicaid | LA | |
| 05979548 | Medicaid | MS |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest University Health Sciences | 4486564952 | 1987 |
News Archive
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
Researchers at LSTM are looking at new ways to create and deliver medications for a wide range of immune-medicated neuropathies, by developing new synthetic versions of the treatment currently seen as the last resort option by doctors; intravenous immunoglobulin (IVIg) therapy.
Sleep deprivation often hits the headlines and we are frequently told we need 8 hours a night. But how much sleep do we really need? Are we sleeping less than we used to and is today's society really sleep deprived? A recent meeting at the Royal Society of Medicine aimed to answer these questions.
QRxPharma Limited announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. The main findings demonstrated that QRxPharma's formulation of MoxDuo IV resulted in fewer side effects and offered better pain relief than morphine alone.
› Verified 8 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
Researchers at LSTM are looking at new ways to create and deliver medications for a wide range of immune-medicated neuropathies, by developing new synthetic versions of the treatment currently seen as the last resort option by doctors; intravenous immunoglobulin (IVIg) therapy.
Sleep deprivation often hits the headlines and we are frequently told we need 8 hours a night. But how much sleep do we really need? Are we sleeping less than we used to and is today's society really sleep deprived? A recent meeting at the Royal Society of Medicine aimed to answer these questions.
QRxPharma Limited announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. The main findings demonstrated that QRxPharma's formulation of MoxDuo IV resulted in fewer side effects and offered better pain relief than morphine alone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alberto L De Hoyos, MD 740 South Limestone, Room A301, Lexington, KY 40536 Ph: (859) 323-6494 | Alberto L De Hoyos, MD 740 South Limestone, Room A301, Lexington, KY 40536 Ph: (859) 323-6494 |
News Archive
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
Researchers at LSTM are looking at new ways to create and deliver medications for a wide range of immune-medicated neuropathies, by developing new synthetic versions of the treatment currently seen as the last resort option by doctors; intravenous immunoglobulin (IVIg) therapy.
Sleep deprivation often hits the headlines and we are frequently told we need 8 hours a night. But how much sleep do we really need? Are we sleeping less than we used to and is today's society really sleep deprived? A recent meeting at the Royal Society of Medicine aimed to answer these questions.
QRxPharma Limited announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. The main findings demonstrated that QRxPharma's formulation of MoxDuo IV resulted in fewer side effects and offered better pain relief than morphine alone.
› Verified 8 days ago
John H Chaney, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1720 Nicholasville Rd Ste 502, Lexington, KY 40503 Phone: 859-260-6850 | |
Hamid R Mohammadzadeh, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1401 Harrodsburg Rd, Suite B-275, Lexington, KY 40504 Phone: 859-278-2334 Fax: 859-278-0159 | |
Dr. Hassan Khalil Reda, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 740 S. Limestone, A301, Lexington, KY 40536 Phone: 859-323-4934 Fax: 859-257-4682 | |
Dr. Suresh Keshavamurthy, M.D Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-6013 | |
Marco Ricci, MD, PHD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone Ste L203, Lexington, KY 40536 Phone: 859-323-6754 Fax: 859-323-3499 | |
Dr. Gary F. Earle, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1720 Nicholasville Rd, Suite 502, Lexington, KY 40503 Phone: 859-277-7129 Fax: 859-277-9613 | |
Rajasekhar Srinivasa Rama Malyala, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-257-1000 |